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Incidence Odds ratio 95% CI p 
ARF 6.9=/0 6.3 3.0-13.3 <0.001 
Minor CK-MB rise 29=/° 2.5 1.2-5.5 <0.05 
Maie. CK-MB rise 13% 3.7 1.5-9.2 <0.01 
'Minor' CPK-MB elevation was associated with a threefold increase in 
late mortality (compared with no CPK-MB rise). 70% of these deaths were 
cardiac; causes included arrhythmia in 42% complications of MI in 26'/0, and 
heart failure in 21%. We conclude: Following ablative NDA In native coronary 
arteries: (1) ARF and CPK-MB elevation are independent predictors of late 
mortality and (2) 'minor' CPK-MB elevations are associated with an excess of 
late cardiac deaths, particularly arrhythrnia deaths. The implications of these 
findings warrant further investigation. 
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~ '~-~ Impact of Artery Disease on Right Coronary 
Complications Outing Treatment of the Left 
Coronary System With the Rotsblator 
Mark Reisman, Vema Harms. Swedish Medical Center, Seattle WA 
High speed rotational ablation can transiently affect laft ventricular function 
in the myocardium subtended by the treated vessel. The remaining vessels 
under these oimumstances may play a greater role in hemodynamic Support. 
To assess the complications of muitivessel disease, we analyzed the mufti- 
center registry (n = 3284 pts). We compared pts receiving treatment of the 
either the LAD or circumflex with a significant stenosis in the RCA (> 70%) 
(Group A, n = 331 pts.) with the remaining subset of patients (Group B, n = 
2953 lots). The following rates of complications were observed: 
No rellow Q MI NunQMI CABG Death 
Gr. A 0% t.~/a 7.6% 4.2% 3.4% 
Gr. B 0.5% 12% 5A% 2.5% 1% 
p 0.38 0.79 0.14 0.10 <0.002 
While the rates of non Qweve MI and CABG tended to be higher in Group A 
the differences were not significant. Only the mortality was significantly higher 
in Group A. Of the 331 patients in Group A, 168 had lesions in the RCA of 
70-99.9% while 163 had 100% occlusions. Eleven deaths occurred in this 
group; 8 in the subgroup with 100% occlusion and 3 in the subgroup with 
70-99% lesions of the RCA, p = 0.06. Conclusion: Patients with significant 
right coronary disease appear to be at increased mortality during Rotsblator 
treatment of the left coronary system. 
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~- . - .~  Mechanisms Bradyarrhythmlas Assoc iated With o |  
Rotat ional  Atherectomy 
Gregory A. Braden, Russell J. Bailey, David M. Fitzgerald, Teresa Young, 
Leslie Uttsy, Robert J. Applegate.. Bowman Gray School of Medicine, 
Medical Center Blvd., Winston Salem, NC 
Rotational atherectomy (RA) frequently produces transient bradyarrhythm:as 
(BA) necessitating temporary pacemaker placemenL Etiologies of these ar- 
rhythmlas may include vagat responses or localized adenosine release. We 
studied heart rate responses during RA in 100 consecutive pts in sinus 
rhythm randomized to one cf four groups to receive atropine (AT = 2 mg IV), 
or aminophylline (AM = 5 mg/kg IV) prior to RA: Group A == double placebo 
(pl); Group B = AT+ ph Group C = pl + AM; Group D = AT + AM. Temporary 
pacemakers (PM) were placed in all pts prior to RA, with demand pacing at 
40 bpm. Endpoints included 8A requiring PM, AV block (AVB), heart rate < 
50 bpm at the end of burr runs, and use of dopamine (DP) for hemodynamic 
support. Results: 94 pts randomized had RA performed. Clinical features 
and vessels treated were similar between groups. Discrete variables were 
examined with x 2 tests; "p _ 0.05 vs Group A. 
Group N PM (%) AVB (%) HR < 50 (%) DP (%) 
A 25 40 16 56 24 
B 24 33 21 17 4* 
C 22 36 14 41 27 
D 23 4* 9 9* 4* 
°p _< 0.05 vs Group A. 
Thus, AM and AT alone partially ameliorated the BA during RA, while the 
combination almost completely abolished them. 
Conclusions: Significant BA are common with RA and may require pac- 
ing or pressor support. Both vagal stimulation and adenosine release are 
important mediators of the bradyarrhythmias during RA. 
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7~' ]  Clinical and Anglographlc Predictors of Adverse 
Cardiac Events After Rotsblator Atherectomy 
Jon J. MoJares, Barry M, Kaplan, William W. O'Neill, Venu M. Reddy, Robert 
D. Safian. William Beaumont Hospital, Royal Oak, Michigan 
Rotablator (MRA) was performed in 337 consecutive lesions (309 patients) 
from August 1993 to September 1994 (age 65 • 12 years and 64% male). 
Pre.lntervention ACCIAHA classification was A (5%), B1 (22%), B2 (32%), 
B3 (23%), B4 (8°/o), B5 (1%), and C (9%). 73=/0 of patients had multivessel 
disease and 76% had a myocardial infarction within 3 months. Angiographic 
predictors of major in-hospital cardiac events (7%) including repeat PTCA, 
MI, CABG, and death were final lumen diameter and residual stsnosts after 
adjunctive PTCA (p < 0.05). Adverse events (AE) at 6 and 17 months 
included repeat pamutaneous intervention (21, 30°/=), CABG (8, 10°/o), target 
vessel revascularization ('TVR) (18, 26%), death (5, 12°/,), and any AE (24, 
38°/,). Event-free survival was 76% at 6 months and 62°/, at 1? months. 
Univarets predictors of TVR and AE were: 
TVR AE 
Younger age p < 0.04 p = NS 
Diabetes p = NS p < 0.03 
Hypertension p < 0.05 p < 0.05 
Bifurcation Lesion p < 0.03 p = NS 
Restenosis lesion p = NS p < 0.007 
Smaller elemnce artery size p < 0.05 p < 0.001 
Other variables not predictive of TVR or AE included gender, cholesterol, 
smoking, anginal class, recent MI, number of vessels diseased, calcification, 
dissection grade, lesion length and luminal results. 
Conclusio,'~s: Younger patients with diabetes, hypertension, a bifurcation 
lesion, a restenosis lesion, and small reference artery size were more likely to 
have adverse events after MRA. A smaller final minimal lumen diameter and 
increased final stenosis were associated with increased in-hospital events, 
but did not predict adverse events during follow up. 
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~ Compl icat ions  With New Angloplasty Oevlces. Are  
These Device Speci f ic?  
Sameer Mehta, Jeffrey Popma, James R. Margolis, Linda Moore, Oscar 
R. Pena. Miami Heart Institute, Miami Beach, FL 
Thrombus, dissection, spasm, perforation, distal embolization, and abrupt 
closure are complications associated with the use of New Angioplasty De- 
vices (NAD). To determine if these adverse outcomes are.NAD specific, 
data from 2233 native cemnary lesions treated with NAD in the NACI Reg- 
istry Angiographic Core Laboratory were examined. NAD included in the 
analysis were Directio.qal Atherectomy (DVI), Extraction Atherectomy (rEC), 
Rotablator (ROTA), Palmatz Schatz Stent (PSS) and Excimer Lasers (AIS, 
SPEC). 
DVl TEC ROTA PSS AIS SPEC 
Thrombus 12 2.1 3.7 0 '~ 1 3.2 
Spasm 0.8 0 4,8 1.2 :-,8 1.1 
Embolism 1.9 0 2.8 0 1.4 0 
Abr. Closure 1.3 8,3 3,7 0 7.4 1.1 
Dissection 9.4 25.0 147 6.5 31.7 33,0 
Perforation < 1 4.2 < 1 0 3,2 3.2 
Conclusions: (1) Excimer Lasers (AIS, SPEC) are associated with in- 
creased rates of dissection and thrombus (AIS), Rotablator with increased 
spasm and embolism and TEC htherectomy with more frequent abrupt cin- 
sure and perforation rates. (2) Anticipation of these device specific adverse 
outcomes may be helpful in their management. 
